Abstract
Circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) are cancer cells that detach from their primary site to circularity system or other body fluids, which hold the promise of monitoring of tumor evolution and therapeutic efficacy and improving prognosis for patients. With the rapid development of detection technologies of CTCs and ctDNA, the sensitivity and specificity of current assays had significant improved. CTCs can be detected by use of cytometry, immunofluorescence analysis and genedetection and the detection methods of ctDNA mainly based on PCR and the next generation sequencing. As the developing of various methods and platforms were developed for detecting the circulating tumor cells and circulating tumor DNA, it is necessary to use the detection technology flexibly according to the research purpose and provide more assistance for the diagnosis and treatment of tumor. Key words: Neoplastic cells, circulating; Circulating tumor DNA; Cell count; High-throughput nucleotide sequencing
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
